ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,767.80
0.77%
Dow Jones
44,477.13
0.39%
Gold vs US Dollar
2,905.295
1.54%
Brent Oil
75.705
1.45%
Bitcoin
97,567.82
1.11%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. ZyVersa Therapeutics Inc (ZVSA) Share Price

ZVSA ZyVersa Therapeutics Inc

1.255
0.03 (2.45%)
Last Updated: 19:02:05
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 ZyVersa Therapeutics Inc NASDAQ:ZVSA NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.03 2.45 1.255 1.23 1.26 1.31 1.20 1.24 89,063 19:02:05   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -106.25M -45.3231 -0.50 2.87M
 Type  Size  Price  Time  Units 
 9 2 1.26 19:02:05 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore ZVSA News
24/01/202521:05EDGAR2Form S-8 - Securities to be offered to employees in employee benefit plans
17/01/202521:05EDGAR2Form DEF 14A - Other definitive proxy statements
30/12/202413:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
27/12/202405:15EDGAR2Form EFFECT - Notice of Effectiveness
20/12/202422:04EDGAR2Form S-3 - Registration statement under Securities Act of 1933
20/12/202421:15EDGAR2Form PRE 14A - Other preliminary proxy statements
18/12/202412:55GLOBEZyVersa Therapeutics’ CEO, Stephen C. Glover, to Attend JPM’s Healthcare Conference 2025 in San Francisco
Period
Draw mode
Data Downloads for ZVSA

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest ZyVersa Therapeutics Inc Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads